LARIMAR THERAPEUTICS
6.9450
08-10月-24 12:32:09
15 分の遅延
株式
+0.4650
+7.18%
本日の幅
6.4500 - 6.9535
ISIN
N/A
ソース
NASDAQ
-
Larimar Therapeutics to Participate in the Guggenheim Genomic Medicines and Rare Disease Days
28 3 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Fourth Quarter and Full Year 2022 Operating and Financial Results
14 3 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Appoints Dr. Gopi Shankar as Chief Development Officer
07 2 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics to Present at the 34th Annual Piper Sandler Healthcare Conference
21 11 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
10 11 2022 07:00:04 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics to Participate in the Guggenheim 4th Annual Immunology & Neurology Day
07 11 2022 16:05:01 提供 Nasdaq GlobeNewswire
-
20 10 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
19 10 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
16 9 2022 13:00:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces $70 Million Underwritten Offering
14 9 2022 07:04:00 提供 Nasdaq GlobeNewswire
-
14 9 2022 07:01:00 提供 Nasdaq GlobeNewswire
-
28 7 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
28 6 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces Upcoming Scientific Conference Presentations
02 6 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
19 5 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
12 5 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
25 3 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Provides Update on CTI-1601 Clinical Program
14 2 2022 16:01:00 提供 Nasdaq GlobeNewswire